Cascades Inc. (TSE:CAS – Get Free Report) was down 3.9% during trading on Thursday . The company traded as low as C$12.21 and last traded at C$12.30. Approximately 91,738 shares were traded during trading, a decline of 60% from the average daily volume of 226,883 shares. The stock had previously closed at C$12.80.
Analyst Upgrades and Downgrades
A number of equities analysts have recently weighed in on CAS shares. Royal Bank of Canada upped their target price on Cascades from C$12.00 to C$13.00 and gave the company a “sector perform” rating in a report on Friday, December 20th. TD Securities upped their price objective on shares of Cascades from C$12.00 to C$14.00 and gave the company a “buy” rating in a research note on Friday, November 8th. CIBC lifted their target price on shares of Cascades from C$12.00 to C$13.00 in a research note on Wednesday, January 15th. Finally, Scotiabank upgraded Cascades from a “hold” rating to a “strong-buy” rating and increased their price objective for the stock from C$12.00 to C$15.50 in a report on Monday, January 27th. Four research analysts have rated the stock with a hold rating, one has given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Cascades presently has a consensus rating of “Moderate Buy” and an average target price of C$13.25.
Cascades Stock Down 6.3 %
About Cascades
Cascades Inc produces, converts, and markets packaging and tissue products in Canada and the United States. The company operates through three segments: Containerboard, Specialty Products, and Tissue Papers. It offers various packaging solutions and tissue products comprised of recycled fibers; tissue papers, comprising parent rolls of virgin and recycled fibres; specialty products, including uncoated recycled boxboards; and containerboards.
Featured Articles
- Five stocks we like better than Cascades
- Canada Bond Market Holiday: How to Invest and Trade
- Tesla: 2 Reasons to Buy, 1 Reason to Run
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Should You Hold NVIDIA Stock for the Long Haul or Trade It?
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Humana Gains Despite Medicare Advantage Losses—What’s the Catch?
Receive News & Ratings for Cascades Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cascades and related companies with MarketBeat.com's FREE daily email newsletter.